Bank of Nova Scotia
GSK icon

Bank of Nova Scotia’s GSK GSK Stock Holding History

Bank of Nova Scotia’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,000
Closed -$324K – 1208
2022
Q3 		$324K Buy
+11,000
New +$417K ﹤0.01% 1030
2020
Q3 		– Sell
-52,445
Closed -$2.67M – 1032
2020
Q2 		$2.67M Buy
+52,445
New +$2.69M 0.01% 523

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of Nova Scotia's GSK Position: Q4 2022 in Review

Bank of Nova Scotia sold out of GSK (GSK) in Q4 2022, closing a stake of 11,000 shares — an estimated $324K sold.

Bank of Nova Scotia first reported a position in GSK in Q2 2020 and held it in 2 quarters. The position peaked at $2.67M in Q2 2020. 814 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Bank of Nova Scotia reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
  • Bank of Nova Scotia sold 11,000 GSK shares in Q4 2022, an estimated $324K.
  • Bank of Nova Scotia first reported a position in GSK in Q2 2020 and held it in 2 quarters.
  • Bank of Nova Scotia's GSK position peaked at $2.67M in Q2 2020.
  • 814 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Bank of Nova Scotia's 13F filing for Q4 2022, filed 9 Feb 2023.